RESEARCHER PROFILE

Ali Ismail Al-Gareeb

← Back to Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences

A

Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Ali Ismail Al-Gareeb works in COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Neuroinflammation and Neurodegeneration Mechanisms. Recorded institutional associations include Mustansiriyah University, Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences.

437Publications
11,168Citations
57H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality

    2022 · 189 citations
  2. Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury

    2019 · 180 citations
  3. A review of the bioactive components and pharmacological properties of Lavandula species

    2023 · 168 citations
  4. Commiphora myrrh: a phytochemical and pharmacological update

    2022 · 153 citations
  5. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus

    2021 · 130 citations
  6. Depression and type 2 diabetes: A causal relationship and mechanistic pathway

    2024 · 122 citations
  7. Pathophysiology of Post-COVID syndromes: a new perspective

    2022 · 122 citations
  8. SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close

    2022 · 118 citations
  9. COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin

    2021 · 113 citations
  10. Morus alba: a comprehensive phytochemical and pharmacological review

    2023 · 112 citations
  11. A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease

    2022 · 105 citations
  12. The Looming Effects of Estrogen in Covid-19: A Rocky Rollout

    2021 · 105 citations
  13. Metformin role in Parkinson’s disease: a double-sword effect

    2023 · 101 citations
  14. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic

    2022 · 89 citations
  15. Impact of Sitagliptin on Non-diabetic Covid-19 Patients

    2021 · 89 citations
  16. Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm

    2021 · 89 citations
  17. Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit

    2024 · 86 citations
  18. NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective

    2023 · 86 citations
  19. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review

    2022 · 86 citations
  20. The beneficial role of autophagy in multiple sclerosis: Yes or No?

    2023 · 85 citations
  21. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals

    2022 · 82 citations
  22. Pros and cons for statins use and risk of Parkinson's disease: An updated perspective

    2023 · 80 citations
  23. COVID-19 and corticosteroids: a narrative review

    2022 · 80 citations
  24. Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects

    2023 · 77 citations
  25. The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19

    2022 · 77 citations

← Return to the university profile